Endogenous dendritic cells mediate the effects of intravenously injected therapeutic immunosuppressive dendritic cells in transplantation

scientific article

Endogenous dendritic cells mediate the effects of intravenously injected therapeutic immunosuppressive dendritic cells in transplantation is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1182/BLOOD-2009-10-251058
P932PMC publication ID2974582
P698PubMed publication ID20576812
P5875ResearchGate publication ID44798870

P2093author name stringZhiliang Wang
Quan Liu
Adrian E Morelli
Adriana T Larregina
Angela Montecalvo
Sherrie J Divito
William J Shufesky
Geza Erdos
Olga A Tkacheva
P2860cites workEndogenous dendritic cells are required for amplification of T cell responses induced by dendritic cell vaccines in vivoQ73100730
Regulatory dendritic cells protect mice from murine acute graft-versus-host disease and leukemia relapseQ73153290
Dendritic cells genetically engineered to express Fas ligand induce donor-specific hyporesponsiveness and prolong allograft survivalQ73289641
The importance of H2 haplotype sharing in the induction of specific unresponsiveness by pretransplant blood transfusionsQ73519039
Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cellsQ73709030
Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survivalQ74015557
Induction of transplant tolerance with immunodominant allopeptide-pulsed host lymphoid and myeloid dendritic cellsQ74415746
Linked suppression of skin graft rejection can operate through indirect recognitionQ77620004
Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4+ T cells, but enrich for antigen-specific Foxp3+ T regulatory cells and promote organ transplant toleranceQ80358513
Mechanism of action of donor-specific transfusion in inducing tolerance: role of donor MHC molecules, donor co-stimulatory molecules, and indirect antigen presentationQ80512682
Exosomes as a short-range mechanism to spread alloantigen between dendritic cells during T cell allorecognitionQ80752561
Use of the inhibitory effect of apoptotic cells on dendritic cells for graft survival via T-cell deletion and regulatory T cellsQ83314647
Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejectionQ93747372
1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activationQ28370605
Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivoQ30080006
In situ-targeting of dendritic cells with donor-derived apoptotic cells restrains indirect allorecognition and ameliorates allograft vasculopathyQ33424530
Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipientsQ35160185
NK cells promote transplant tolerance by killing donor antigen-presenting cellsQ36228823
Indirect recognition by helper cells can induce donor-specific cytotoxic T lymphocytes in vivoQ36362829
Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell toleranceQ36376611
Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cellsQ36401207
Tolerogenic dendritic cells and the quest for transplant toleranceQ36879029
Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-kappa B oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-IgQ38363193
Targeting MHC class I monomers to dendritic cells inhibits the indirect pathway of allorecognition and the production of IgG alloantibodies leading to long-term allograft survival.Q39908894
Donor-specific transfusion and donor bone marrow infusion in renal transplantation tolerance: a review of efficacy and mechanismsQ40373804
Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivoQ40752701
Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLsQ41057373
Retrospective and prospective studies on the effect of blood transfusions in renal transplantation in The NetherlandsQ41151625
Deliberate donor-specific blood transfusions prior to living related renal transplantation. A new approachQ41487486
Modified dendritic cells coexpressing self and allogeneic major histocompatability complex molecules: an efficient way to induce indirect pathway regulationQ44807533
Location and time-dependent control of rejection by regulatory T cells culminates in a failure to generate memory T cellsQ46602684
Marked prolongation of murine cardiac allograft survival using recipient immature dendritic cells loaded with donor-derived apoptotic cellsQ47384056
Determination of the IgG2a allotype of CXB recombinant inbred mouse strains by a PCR-based methodQ47916605
Infusion of stably immature monocyte-derived dendritic cells plus CTLA4Ig modulates alloimmune reactivity in rhesus macaques.Q50946765
Dendritic cells activated by lipopolysaccharide after dexamethasone treatment induce donor-specific allograft hyporesponsiveness.Q51982170
Internalization of circulating apoptotic cells by splenic marginal zone dendritic cells: dependence on complement receptors and effect on cytokine production.Q52547955
Immunological unresponsiveness induced by recipient cells transfected with donor MHC genes.Q53728143
The effect of donor strain blood pretreatment on renal allograft rejection in ratsQ53849910
Planned preimmunization of renal allograft recipients.Q53933481
Generation of therapeutic dendritic cells and regulatory T cells for preventing allogeneic cardiac graft rejectionQ56900558
"Alternatively activated" dendritic cells preferentially secrete IL-10, expand Foxp3+CD4+ T cells, and induce long-term organ allograft survival in combination with CTLA4-IgQ56901846
Induction of CD4+/CD25+ regulatory T cells by targeting of antigens to immature dendritic cellsQ56903879
Expression of B7 molecules in recipient, not donor, mice determines the survival of cardiac allograftsQ56906704
Differential MHC class II synthesis and ubiquitination confers distinct antigen-presenting properties on conventional and plasmacytoid dendritic cellsQ57134111
Migratory Dendritic Cells Transfer Antigen to a Lymph Node-Resident Dendritic Cell Population for Efficient CTL PrimingQ57227729
Mechanisms of donor-specific transfusion tolerance: preemptive induction of clonal T-cell exhaustion via indirect presentationQ60997248
Effect of blood transfusions on subsequent kidney transplantsQ69250652
Genetics of the blood transfusion effect on heart allografts in ratsQ70365718
Comparison of immune responsiveness in mice after single or multiple donor-specific transfusionsQ72720684
Immature rat myeloid dendritic cells generated in low-dose granulocyte macrophage-colony stimulating factor prolong donor-specific rat cardiac allograft survivalQ73045866
P433issue15
P407language of work or nameEnglishQ1860
P921main subjectdendritic cellQ506253
P304page(s)2694-2705
P577publication date2010-06-24
P1433published inBloodQ885070
P1476titleEndogenous dendritic cells mediate the effects of intravenously injected therapeutic immunosuppressive dendritic cells in transplantation
P478volume116

Reverse relations

cites work (P2860)
Q36578322Alternative approaches to myeloid suppressor cell therapy in transplantation: comparing regulatory macrophages to tolerogenic DCs and MDSCs
Q36238593Autologous dendritic cells prolong allograft survival through Tmem176b-dependent antigen cross-presentation
Q38078105Cell therapy using tolerogenic dendritic cells in transplantation
Q36880118Concise Review: Mechanisms Behind Apoptotic Cell-Based Therapies Against Transplant Rejection and Graft versus Host Disease
Q36002657Dendritic cell therapies in transplantation revisited: deletion of recipient DCs deters the effect of therapeutic DCs
Q38059518Dendritic cell therapy for Type 1 diabetes suppression
Q21284774Dendritic cell-based approaches for therapeutic immune regulation in solid-organ transplantation
Q37316849Donor bone marrow-derived dendritic cells prolong corneal allograft survival and promote an intragraft immunoregulatory milieu.
Q37137864Donor dendritic cell-derived exosomes promote allograft-targeting immune response
Q35865098Donor-derived, tolerogenic dendritic cells suppress immune rejection in the indirect allosensitization-dominant setting of corneal transplantation
Q38071421Experimental models to investigate the function of dendritic cell subsets: challenges and implications
Q90529882Generation and functional assessment of nonhuman primate regulatory dendritic cells and their therapeutic efficacy in renal transplantation
Q38682156Harnessing the properties of dendritic cells in the pursuit of immunological tolerance
Q50023625High PD-L1/CD86 MFI ratio and IL-10 secretion characterize human regulatory dendritic cells generated for clinical testing in organ transplantation
Q35692028Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes.
Q36761540Neurokinin-1 receptor agonists bias therapeutic dendritic cells to induce type 1 immunity by licensing host dendritic cells to produce IL-12
Q38955064Novel Insights Into the Immunoregulatory Function and Localization of Dendritic Cells
Q37662989Old game, new players: Linking classical theories to new trends in transplant immunology
Q34379951Orchestration of transplantation tolerance by regulatory dendritic cell therapy or in-situ targeting of dendritic cells
Q37040247Origin and biology of the allogeneic response
Q26767458Prospective Clinical Testing of Regulatory Dendritic Cells in Organ Transplantation
Q87806866Rapid tolerance induction by hematopoietic progenitor cells in the absence of donor-matched lymphoid cells
Q92303151Regulatory dendritic cells for human organ transplantation
Q50177437Regulatory dendritic cells for promotion of liver transplant operational tolerance: Rationale for a clinical trial and accompanying mechanistic studies.
Q90413377Regulatory dendritic cells: profiling, targeting, and therapeutic application
Q26999875Regulatory myeloid cells in transplantation
Q50993283Renal Allograft Survival in Nonhuman Primates Infused With Donor Antigen-Pulsed Autologous Regulatory Dendritic Cells.
Q30278837Sphingosine 1-Phosphate Receptor 3-Deficient Dendritic Cells Modulate Splenic Responses to Ischemia-Reperfusion Injury
Q56967224TIGIT iTregs elicited by human regulatory macrophages control T cell immunity
Q38256369Tolerance in organ transplantation: from conventional immunosuppression to extracellular vesicles.
Q52665595Tolerogenic Dendritic Cells in Solid Organ Transplantation: Where Do We Stand?
Q37077325Tolerogenic Donor-Derived Dendritic Cells Risk Sensitization In Vivo owing to Processing and Presentation by Recipient APCs.
Q39013872Tolerogenic dendritic cell therapy in organ transplantation
Q21131223Tolerogenic dendritic cells and negative vaccination in transplantation: from rodents to clinical trials
Q35341379Tolerogenic dendritic cells and their role in transplantation.
Q38339535Tolerogenic dendritic cells: role and therapeutic implications in systemic lupus erythematosus.
Q38114067Transplant tolerance: new insights and strategies for long-term allograft acceptance
Q47121682Update on Dendritic Cell-Induced Immunological and Clinical Tolerance.
Q55662835Upregulation of Heme Oxygenase-1 Endues Immature Dendritic Cells With More Potent and Durable Immunoregulatory Properties and Promotes Engraftment in a Stringent Mouse Cardiac Allotransplant Model.
Q37869483What is the role of antigen-processing mechanisms in autologous tolerogenic dendritic cell therapy in organ transplantation?